Cost of managing brain metastases in ALK-positive advanced NSCLC patients receiving first-line ALK TKIs in China [0.03%]
中国ALK阳性晚期NSCLC一线TKI治疗患者脑转移的治疗成本分析研究
Bingqi Hu,Jing Xue,Dingsiman Li et al.
Bingqi Hu et al.
Aim: To estimate brain metastases (BM) management costs in Chinese ALK+ advanced non-small-cell lung cancer (NSCLC) patients receiving first-line (1 L) ALK tyrosine kinase inhibitors (TKIs). ...
Leveraging machine learning to predict de novo skin malignancy following lung transplantation [0.03%]
利用机器学习预测肺移植后皮肤恶性肿瘤的发生
Nasim Nosoudi,Amir Zadeh,Rayna Nichols et al.
Nasim Nosoudi et al.
Aims: This study aimed to predict post-transplant malignancy risks at multiple levels among lung transplant recipients using machine learning (ML) and to identify key clinical and immunogenetic predictors. ...
Rucaparib in refractory pleural mesothelioma harboring somatic pathogenic BRCA1 and BRCA2 mutation. A report of two cases [0.03%]
rucaparib治疗复发性含BRCA1/2胚系致病突变的恶性胸膜间皮瘤两例报道
Luigi Cerbone,Benedetta Del Rio,Sara Delfanti et al.
Luigi Cerbone et al.
Pleural mesothelioma is a rare disease with few therapeutic options, especially in the first line refractory setting. Targeted agents did not demonstrate a significant clinical benefit in mesothelioma treatment, nevertheless a small group o...
Construction and validation of an oxidative phosphorylation-related gene signature in lung squamous cell carcinoma patients [0.03%]
构建和验证肺鳞癌患者的氧化磷酸化相关基因特征模型及预后列线图模型
Ninghuang Dai,Chen Fang,Yu Gu et al.
Ninghuang Dai et al.
Background: Metabolic reprogramming, particularly toward oxidative phosphorylation (OXPHOS), is a hallmark of lung squamous cell carcinoma (LUSC) and contributes to its aggressive phenotype and immunosuppressive microenvi...
Negative social determinants of health are linked to lung cancer screening underutilization [0.03%]
负面的社会健康决定因素与肺癌筛查利用率低有关
Vuong V Do,Eduardo R Núñez,Fatima G Wilder et al.
Vuong V Do et al.
Introduction: This study aimed to examine the association between social determinants of health (SDOH) and lung cancer screening (LCS) utilization. Method...
Oncogenic ALK fusion in rare subtype of small intestine metastasis from occult lung cancer [0.03%]
隐匿性肺癌罕见亚型小肠转移的致癌ALK融合变异
Tianhua Liu,Yizhuo Chen,Ziqing Xu et al.
Tianhua Liu et al.
We present the case of a 66-year-old male patient who was found to have a lung nodule during the perioperative period for poorly differentiated carcinoma of the ileocecal region. Subsequent surgical procedures were performed to remove the i...
Lung cancer screening in limited resource regions: the 3rd Brazilian Early Lung Cancer Trial (BRELT3/mobile ProPulmão) [0.03%]
低资源区域肺癌筛查：第3届巴西早期肺癌试验（移动ProPulmão）
Ricardo Sales Dos Santos,Ricardo G Figueiredo,Juliana P Franceschini et al.
Ricardo Sales Dos Santos et al.
Aims: To describe tomographic findings in a high-risk lung cancer population in resource-limited Brazilian areas, quantify pulmonary nodules and lung cancer frequency, analyze challenges in lung cancer screening within th...
The association between blood-based HYAL2 methylation and early-stage lung cancer: a case-control study [0.03%]
血清HYAL2甲基化与早期肺癌相关性的横断面研究
Rong Qiao,Xiajie Zhou,Wenli Li et al.
Rong Qiao et al.
Background: Blood-based DNA methylation biomarkers have great potential for the early detection of lung cancer (LC). Here, we investigated the association between HYAL2 methylation in peripheral blood and LC. ...
Pooled analysis of oral vinorelbine as single agents in patients with advanced NSCLC [0.03%]
口服长春瑞滨单药用于晚期NSCLC患者的汇集分析
Christos Chouaid,Francesco Grossi,Christine Ta Thanh Minh et al.
Christos Chouaid et al.
Objectives: This was a pooled analysis of data from weekly vinorelbine (VNR) treatment arms of four individual open-label, phase II studies to assess and refine the efficacy and tolerance of weekly oral VNR in a larger co...
Moving towards single fraction peripheral lung stereotactic body radiation therapy: patient care during and after the global COVID-19 pandemic [0.03%]
迈向单次分割的肺立体定向放射治疗：全球COVID-19大流行期间及之后患者的护理措施
Salem Alfaifi,Vibhay Pareek,Julian Kim et al.
Salem Alfaifi et al.
Aim/objectives: Single-fraction stereotactic body radiation therapy (SF-SBRT) for peripheral lung tumors was reviewed. Materials & methods: Medically inoperable peripheral lung tumors eligible for SF-SBRT 34 Gray were treated. Patient chara...